P
RVMD icon

&Partners’s Revolution Medicines RVMD Stock Holding History

&Partners’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Buy
+3,474
New +$507K ﹤0.01% 1664

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

&Partners's RVMD Position: Q2 2026 in Review

&Partners opened a new position in Revolution Medicines (RVMD) in Q2 2026: 3,474 shares worth $671K. The stake represents ﹤0.01% of the portfolio and ranks #1664 among its holdings.

689 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • &Partners held 3,474 shares of Revolution Medicines worth $671K as of Q2 2026.
  • Revolution Medicines was a new &Partners position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1664 holding.
  • 689 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.